Skip to main content
Erschienen in: Surgery Today 5/2014

01.05.2014 | Case Report

Hepatopancreatoduodenectomy for anastomotic recurrence from residual cholangiocarcinoma: report of a case

verfasst von: Seiji Natsume, Tomoki Ebata, Yukihiro Yokoyama, Tsuyoshi Igami, Gen Sugawara, Yu Takahashi, Masato Nagino

Erschienen in: Surgery Today | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Resection of cholangiocarcinoma often results in a positive ductal margin, from carcinoma in situ (CIS) near the main tumor; however, the biological behavior of the residual CIS after surgical resection remains equivocal. We report a case of late local recurrence of CIS, defined as long-term tumor progression from CIS residue at the ductal stump. The patient, a 73-year-old man, had undergone bile duct resection for distal cholangiocarcinoma, leaving positive ductal margins with CIS. A biliary stricture was found 10 years later at the site of anastomosis, and right hepatectomy with pancreatoduodenectomy was performed. Based on histological analogy and the evidence of remnant CIS, a final diagnosis of late local recurrence from the CIS foci was made. This uncommon mode of recurrence should be considered in patients with early-stage disease with expected favorable survival because salvage surgery is feasible for selected patients.
Literatur
1.
Zurück zum Zitat Ebata T, Nagino M, Nishio H, Arai T, Nimura Y. Pathological appraisal of lines of resection for bile duct carcinoma. Br J Surg. 2002;89:1260–7.PubMedCrossRef Ebata T, Nagino M, Nishio H, Arai T, Nimura Y. Pathological appraisal of lines of resection for bile duct carcinoma. Br J Surg. 2002;89:1260–7.PubMedCrossRef
2.
Zurück zum Zitat Igami T, Nagino M, Oda K, Nishio H, Ebata T, Yokoyama Y, et al. Clinicopathologic study of cholangiocarcinoma with superficial spread. Ann Surg. 2009;249:296–302.PubMedCrossRef Igami T, Nagino M, Oda K, Nishio H, Ebata T, Yokoyama Y, et al. Clinicopathologic study of cholangiocarcinoma with superficial spread. Ann Surg. 2009;249:296–302.PubMedCrossRef
3.
Zurück zum Zitat Nakanuma Y, Harada K, Ishikawa A, Zen Y, Sasaki M. Anatomic and molecular pathology of intrahepatic cholangiocarcinoma. J Hepatobilliary Pancreat Surg. 2003;10:265–81.CrossRef Nakanuma Y, Harada K, Ishikawa A, Zen Y, Sasaki M. Anatomic and molecular pathology of intrahepatic cholangiocarcinoma. J Hepatobilliary Pancreat Surg. 2003;10:265–81.CrossRef
4.
Zurück zum Zitat Nakanishi Y, Kondo S, Zen Y, Yonemori A, Kubota K, Kawakami H, et al. Impact of residual in situ carcinoma on postoperative survival in 125 patients with extrahepatic bile duct carcinoma. J Hepatobiliary Pancreat Sci. 2010;17:166–73.PubMedCrossRef Nakanishi Y, Kondo S, Zen Y, Yonemori A, Kubota K, Kawakami H, et al. Impact of residual in situ carcinoma on postoperative survival in 125 patients with extrahepatic bile duct carcinoma. J Hepatobiliary Pancreat Sci. 2010;17:166–73.PubMedCrossRef
5.
Zurück zum Zitat Wakai T, Shirai Y, Moroda T, Yokoyama N, Hatakeyama K. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma. Cancer. 2005;103:1210–6.PubMedCrossRef Wakai T, Shirai Y, Moroda T, Yokoyama N, Hatakeyama K. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma. Cancer. 2005;103:1210–6.PubMedCrossRef
6.
Zurück zum Zitat Hibi T, Sakamoto Y, Tochigi N, Ojima H, Shimada K, Sano T, et al. Extended right hemihepatectomy as a salvage operation for recurrent bile duct cancer 3 years after pancreatoduodenectomy. Jpn J Clin Oncol. 2006;36:176–9.PubMedCrossRef Hibi T, Sakamoto Y, Tochigi N, Ojima H, Shimada K, Sano T, et al. Extended right hemihepatectomy as a salvage operation for recurrent bile duct cancer 3 years after pancreatoduodenectomy. Jpn J Clin Oncol. 2006;36:176–9.PubMedCrossRef
7.
Zurück zum Zitat Nakanishi Y, Kondo S, Hirano S, Ambo Y, Tanaka E, Morikawa T, et al. Recurrence of mucosal carcinoma of the bile duct, with superficial flat spread, 12 years after operation. J Hepatobiliary Pancreat Surg. 2006;13:355–8.PubMedCrossRef Nakanishi Y, Kondo S, Hirano S, Ambo Y, Tanaka E, Morikawa T, et al. Recurrence of mucosal carcinoma of the bile duct, with superficial flat spread, 12 years after operation. J Hepatobiliary Pancreat Surg. 2006;13:355–8.PubMedCrossRef
8.
Zurück zum Zitat Sasaki T, Kondo S, Ambo Y, Hirano S, Sichinohe T, Kaga K, et al. Local recurrence at hepaticojejunostomy 9 years after resection of bile duct cancer with superficial flat spread. J Hepatobiliary Pancreat Surg. 2006;13:458–62.PubMedCrossRef Sasaki T, Kondo S, Ambo Y, Hirano S, Sichinohe T, Kaga K, et al. Local recurrence at hepaticojejunostomy 9 years after resection of bile duct cancer with superficial flat spread. J Hepatobiliary Pancreat Surg. 2006;13:458–62.PubMedCrossRef
9.
Zurück zum Zitat Tanaka N, Nobori M. KohzumaT, Suzuki Y, Saiki S. Anastomotic recurrence at hepaticojejunostomy in a long-term survivor of bile duct carcinoma: report of a case. Surg Today. 1994;24:280–4.PubMedCrossRef Tanaka N, Nobori M. KohzumaT, Suzuki Y, Saiki S. Anastomotic recurrence at hepaticojejunostomy in a long-term survivor of bile duct carcinoma: report of a case. Surg Today. 1994;24:280–4.PubMedCrossRef
10.
Zurück zum Zitat Bassi C, Dervenis C, Butturini G, Finqerhut A, Yeo C, Izbicki J, et al. Post operative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8–13.PubMedCrossRef Bassi C, Dervenis C, Butturini G, Finqerhut A, Yeo C, Izbicki J, et al. Post operative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8–13.PubMedCrossRef
11.
Zurück zum Zitat International Union Against Cancer (UICC). TNM classification of malignant tumors. 7th ed. New York: Wiley; 2009. International Union Against Cancer (UICC). TNM classification of malignant tumors. 7th ed. New York: Wiley; 2009.
12.
Zurück zum Zitat Kobayashi A, Miwa S, Nakata T, Miyagawa S. Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma. Br J Surg. 2010;97:56–64.PubMedCrossRef Kobayashi A, Miwa S, Nakata T, Miyagawa S. Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma. Br J Surg. 2010;97:56–64.PubMedCrossRef
13.
Zurück zum Zitat Konishi M, Iwasaki M, Ochiai A, Hasebe T, Ojima H, Yanagisawa A. Clinical impact of intraoperative histological examination of the ductal resection margin in extrahepatic cholangiocarcinoma. Br J Surg. 2010;97:1363–8.PubMedCrossRef Konishi M, Iwasaki M, Ochiai A, Hasebe T, Ojima H, Yanagisawa A. Clinical impact of intraoperative histological examination of the ductal resection margin in extrahepatic cholangiocarcinoma. Br J Surg. 2010;97:1363–8.PubMedCrossRef
14.
Zurück zum Zitat Endo I, House MG, Klimstra DS, Gönen M, D’Angelica M, Dematteo RP, et al. Clinical significance of intraoperative bile duct margin assessment for hilar cholangiocarcinoma. Ann Surg Oncol. 2008;15:2104–12.PubMedCrossRef Endo I, House MG, Klimstra DS, Gönen M, D’Angelica M, Dematteo RP, et al. Clinical significance of intraoperative bile duct margin assessment for hilar cholangiocarcinoma. Ann Surg Oncol. 2008;15:2104–12.PubMedCrossRef
15.
Zurück zum Zitat Sasaki R, Takeda Y, Funato O, Nitta H, Kawamura H, Uesugi N, et al. Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma. World J Surg. 2007;31:1788–96.PubMedCrossRef Sasaki R, Takeda Y, Funato O, Nitta H, Kawamura H, Uesugi N, et al. Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma. World J Surg. 2007;31:1788–96.PubMedCrossRef
16.
Zurück zum Zitat Tocchi A, Mazzoni G, Liotta G, Lepre L, Cassini D, Miccini M. Late development of bile duct cancer in patients who had biliary-enteric drainage for benign disease: a follow-up study of more than 1,000 patients. Ann Surg. 2001;234:210–4.PubMedCentralPubMedCrossRef Tocchi A, Mazzoni G, Liotta G, Lepre L, Cassini D, Miccini M. Late development of bile duct cancer in patients who had biliary-enteric drainage for benign disease: a follow-up study of more than 1,000 patients. Ann Surg. 2001;234:210–4.PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat Suzuki M, Takahashi T, Ouchi K, Matsuno S. The development and extension of hepatohilar bile duct carcinoma. A three-dimensional tumor mapping in the intrahepatic biliary tree visualized with the aid of a graphics computer system. Cancer. 1989;64:658–66.PubMedCrossRef Suzuki M, Takahashi T, Ouchi K, Matsuno S. The development and extension of hepatohilar bile duct carcinoma. A three-dimensional tumor mapping in the intrahepatic biliary tree visualized with the aid of a graphics computer system. Cancer. 1989;64:658–66.PubMedCrossRef
18.
Zurück zum Zitat Takahashi Y, Nagino M, Nishio H, Ebata T, Igami T, Nimura Y. Percutaneous transhepatic biliary drainage catheter tract recurrence in cholangiocarcinoma. Br J Surg. 2010;97:1860–6.PubMedCrossRef Takahashi Y, Nagino M, Nishio H, Ebata T, Igami T, Nimura Y. Percutaneous transhepatic biliary drainage catheter tract recurrence in cholangiocarcinoma. Br J Surg. 2010;97:1860–6.PubMedCrossRef
19.
Zurück zum Zitat Yoon YS, Kim SW, Jang JY, Park YH. Curative reoperation for recurrent cancer of the extrahepatic bile duct: report of two cases. Hepatogastroenterology. 2005;52:381–4.PubMed Yoon YS, Kim SW, Jang JY, Park YH. Curative reoperation for recurrent cancer of the extrahepatic bile duct: report of two cases. Hepatogastroenterology. 2005;52:381–4.PubMed
20.
Zurück zum Zitat Seki H, Miyagawa S, Kobayashi A, Kawasaki S. Surgical treatment for biliary carcinoma arising after pancreatoduodenectomy. HPB Surg. 1998;10:395–7.PubMedCentralPubMedCrossRef Seki H, Miyagawa S, Kobayashi A, Kawasaki S. Surgical treatment for biliary carcinoma arising after pancreatoduodenectomy. HPB Surg. 1998;10:395–7.PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Targarona EM, Zografos G, Habib NA. Liver resection for recurrent hilar cholangiocarcinoma. Br J Surg. 1993;80:1433.PubMedCrossRef Targarona EM, Zografos G, Habib NA. Liver resection for recurrent hilar cholangiocarcinoma. Br J Surg. 1993;80:1433.PubMedCrossRef
22.
Zurück zum Zitat Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y, et al. Hepatopancreatoduodenectomy for cholangiocarcinoma: A single-center review of 85 consecutive patients. Ann Surg (in press). Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y, et al. Hepatopancreatoduodenectomy for cholangiocarcinoma: A single-center review of 85 consecutive patients. Ann Surg (in press).
Metadaten
Titel
Hepatopancreatoduodenectomy for anastomotic recurrence from residual cholangiocarcinoma: report of a case
verfasst von
Seiji Natsume
Tomoki Ebata
Yukihiro Yokoyama
Tsuyoshi Igami
Gen Sugawara
Yu Takahashi
Masato Nagino
Publikationsdatum
01.05.2014
Verlag
Springer Japan
Erschienen in
Surgery Today / Ausgabe 5/2014
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-013-0578-5

Weitere Artikel der Ausgabe 5/2014

Surgery Today 5/2014 Zur Ausgabe

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 49 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Wie der Klimawandel gefährliche Pilzinfektionen begünstigt

24.05.2024 Candida-Mykosen Nachrichten

Dass sich invasive Pilzinfektionen in letzter Zeit weltweit häufen, liegt wahrscheinlich auch am Klimawandel. Ausbrüche mit dem Hefepilz Candida auris stellen eine zunehmende Gefahr für Immungeschwächte dar – auch in Deutschland.

So wirken verschiedene Alkoholika auf den Blutdruck

23.05.2024 Störungen durch Alkohol Nachrichten

Je mehr Alkohol Menschen pro Woche trinken, desto mehr steigt ihr Blutdruck, legen Daten aus Dänemark nahe. Ob es dabei auch auf die Art des Alkohols ankommt, wurde ebenfalls untersucht.

Das sind die führenden Symptome junger Darmkrebspatienten

Darmkrebserkrankungen in jüngeren Jahren sind ein zunehmendes Problem, das häufig längere Zeit übersehen wird, gerade weil die Patienten noch nicht alt sind. Welche Anzeichen Ärzte stutzig machen sollten, hat eine Metaanalyse herausgearbeitet.

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.